- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04167826
Oral Health Status and Diet History Analysis Among Orphan House Children From 10-14 Years in Cairo Governorate.
November 18, 2019 updated by: Abdulrahman mohamed salah, Cairo University
Oral Health Status and Diet History Analysis Among Orphan House Children From 10-14 Years in Cairo Governorate : A Cross Sectional Study
the purpose of study to determine oral health status and dietary habits among group of orphan children from 10-14 years in Cairo Governorate.
Study Overview
Status
Unknown
Conditions
Detailed Description
The study's investigators will record all data related to oral health status of orphan children from 10-14 years and their dietary habits to describe usual food intake and its variation over a long period of time .
the OHI-S will also recorded which has 2 components the Debris index and Calculus index .
Study Type
Observational
Enrollment (Anticipated)
115
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
10 years to 14 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
This study will done for Orphan children in Resalaa charity organization in Cairo governorate in Egypt.
Description
Inclusion Criteria:
- Egyptian children aged from 10-14 years
- Cooperative children
Exclusion Criteria:
- Children with systemic disease , genetic disorders , or any disabilities
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
oral health status
Time Frame: 3 months
|
Debris index
|
3 months
|
|
oral health status
Time Frame: 3 months
|
Calculus index
|
3 months
|
|
Diet history analysis
Time Frame: 3 months
|
Diet history chart
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Sherine Ezz eldeen, professor, Cairo university
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
November 1, 2019
Primary Completion (Anticipated)
February 1, 2020
Study Completion (Anticipated)
September 1, 2020
Study Registration Dates
First Submitted
November 14, 2019
First Submitted That Met QC Criteria
November 18, 2019
First Posted (Actual)
November 19, 2019
Study Record Updates
Last Update Posted (Actual)
November 19, 2019
Last Update Submitted That Met QC Criteria
November 18, 2019
Last Verified
November 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CEBD-CU-2019-11-14
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gingival Disease Due to Bacteria
-
Ministry of Health, RwandaUnknownDisease Due to Gram-positive BacteriaRwanda
-
Catholic University of the Sacred HeartUniversity Hospital, Geneva; Universiteit Antwerpen; Clinical Centre of Serbia; Canisius-Wilhelmina Hospital and other collaboratorsUnknownInfection Due to ESBL Bacteria | Bacterial Resistance | Infection Resistant to Multiple Drugs | Staph Aureus Methicillin Resistant ColonizationItaly, Romania, Serbia
-
Suez Canal UniversityCompletedGummy Smile Due to Hypermobile Upper Lip | Excessive Gingival DisplayEgypt
-
University Hospital, Basel, SwitzerlandStiftung Forschung Infektionskrankheiten, Basel, SwitzerlandCompletedGroup B Streptococcal Infection | Infection Due to ESBL BacteriaSwitzerland
-
St. Lawrence Health SystemNot yet recruitingInterstitial Lung Disease Due to Systemic Disease | Interstitial Lung Disease Due to Systemic Disease (Disorder) | Interstitial Lung Disease in Patients With Rheumatoid ArthritisUnited States
-
Association Clinique Thérapeutique Infantile du...PfizerCompletedAntibiotic Prescription | Complications | Risk Factors | Outcome, Fatal | Intensive Care Unit | Multi-antibiotic Resistance | Infection Due to Resistant Bacteria | Healing | Hospital DischargeFrance
-
Johann DD PitoutMerck Sharp & Dohme LLCCompletedInfection Due to Resistant BacteriaCanada
-
Hannover Medical SchoolCompletedAcute Kidney Injury | Infection Due to Resistant BacteriaGermany
-
Vestre Viken Hospital TrustUniversity of Oslo; University Hospital of North Norway; Helse Sor-OstCompletedUrinary Tract Infection | Infection Due to ESBL Bacteria | Environmental Contamination of ESBL
-
Connie PriceUnited States Department of Defense; Accelerate Diagnostics, Inc.CompletedInfection | Skin and Subcutaneous Tissue Bacterial Infections | Healthcare-associated Infection | Infection Due to Resistant BacteriaUnited States